ETFIQData as of Nov 18, 2026. · etfiq.com/funds/bgig

BGIG Fact Sheet: Bahl & Gaynor Income Growth ETF

Share
$35.98
close, Nov 18, 2026

Over the year to Nov 18, 2026, BGIG returned +14.8% in total and charged 0.45% a year.

1-year total return
+14.8%
to Nov 18, 2026
Expense ratio
0.45%
a year
Net assets
$2.3bn
on Nov 17, 2026
Net flow, last 5 trading days
+$746k
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

BGIG $11,482 +14.8% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month−0.5%
3 months−2.7%
Year to date+12.9%
1 year+14.8%
3 years+57.4%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
Broadcom Inc4.87%
UnitedHealth Group Inc4.84%
Eli Lilly & Co4.44%
PNC Financial Services Group I4.11%
TSMC4.05%
Johnson & Johnson4.03%
AbbVie Inc3.51%
Microsoft Corp3.39%
Williams Cos Inc3.26%
Apollo Global Management Inc3.19%

BGIG top ten by weight, 39.7% of the fund, of its 50 equity positions, from the holdings filed for Jun 30, 2026.

Facts

Equity fund · Actively managed · First traded Sep 15, 2023 · Benchmark Its own holdings, as of Jun 30, 2026; its prospectus names no index it tracks

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, BGIG Fact Sheet: Bahl & Gaynor Income Growth ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/bgig/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/bgig.